Similar articles

• Possible mechanism of the low tolerance capacity of azidomorphine and azidocodeine.

  Knoll J, Zsilla G. Knoll J, et al. Biochem Pharmacol. 1974 Feb 1;23(3):745-50. doi: 10.1016/0006-2952(74)90639-x. Biochem Pharmacol. 1974. PMID: 4822754 No abstract available.
• Circulatory, respiratory and antitussive effects of azidomorphine and related substances.

  Knoll J, Makleit S, Friedmann T, Hársing LG Jr, Hadházy P. Knoll J, et al. Arch Int Pharmacodyn Ther. 1974 Aug;210(2):241-9. Arch Int Pharmacodyn Ther. 1974. PMID: 4441191 No abstract available.
• The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydrohomopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. II. Toxicity and analgetic effect of MZ-144 compared to narcotic and non-narcotic analgesics.

  Knoll J, Fürst S, Mészáros Z. Knoll J, et al. Arzneimittelforschung. 1971 May;21(5):719-27. Arzneimittelforschung. 1971. PMID: 4328269 No abstract available.
• Antagonists in the 5-phenyl-benzomorphan series.

  Clarke FH, Hill RT, Saelens JK, Yokoyama N. Clarke FH, et al. Adv Biochem Psychopharmacol. 1973;8(0):81-9. Adv Biochem Psychopharmacol. 1973. PMID: 4211809 Review. No abstract available.
• [Conjugated metabolites of morphine and the related compounds and their pharmacological activity (author's transl)].

  Oguri K. Oguri K. Yakugaku Zasshi. 1980 Feb;100(2):117-25. doi: 10.1248/yakushi1947.100.2_117. Yakugaku Zasshi. 1980. PMID: 6245203 Review. Japanese. No abstract available.